Saturday 17 October 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.
457.58
10.92
−2.33%
Follow HCA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(924.11%) | (612.27%) | (397.78%) | (307.62%) | |
Piotroski F-Score |
8 | 7 | 8 | 8 | |
| 10.64% | 11.28% | 11.21% | 11.14% | ||
ROIC |
17.68% | 17.64% | 17.06% | 16.68% | |
Return on Tangible Assets |
22.69% | 22.19% | 24.04% | 21.58% | |
Average Days of Receivables |
51.18 | 52.47 | 54.11 | 57.46 | |
Free Cash Flow per Share |
34.76 | 32.54 | 35.45 | 27.19 | |
Free Cash Flow |
8,096.00 | 7,692.00 | 7,927.00 | 5,997.00 | |
Capital Expenditures |
(4,740.00) | (4,944.00) | (5,072.00) | (5,127.00) | |
| Other line items | |||||
Cash ROIC |
18.68% | 17.18% | 17.24% | 12.62% | |
Accounts Receivable Turnover |
7.31 | 6.99 | 6.82 | 6.86 | |
Accounts Payable Turnover |
2.55 | 2.54 | 2.47 | 2.55 | |
Inventory Turnover |
6.37 | 6.71 | 6.59 | 6.66 | |
Average Days of Payables |
148.57 | 149.60 | 153.12 | 150.85 | |
Days of Inventory on Hand |
56.60 | 53.05 | 53.56 | 52.76 | |
Tax Rate |
(0.21) | (0.21) | (0.20) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.59% | 43.46% | 43.39% | 42.68% | |
Share Based Compensation of Revenue |
0.52% | 0.53% | 0.51% | 0.48% | |
Interest Coverage |
5.31 | 5.36 | 5.27 | 5.24 | |
Operating CF/Net income |
2.02 | 1.86 | 1.91 | 1.63 | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.12 | 0.12 | |
Capex/Depreciation |
(1.35) | (1.39) | (1.39) | (1.38) | |
Revenue per Share |
319.34 | 319.78 | 341.65 | 353.74 | |
Operating CF per Share |
55.12 | 53.45 | 58.14 | 50.44 | |
Capex per Share |
(20.35) | (20.91) | (22.68) | (23.25) | |
Capex to Sales |
0.06 | 0.07 | 0.07 | 0.07 |
Columns are period end dates